Bryan Johnson
Tech entrepreneur; 'Blueprint' / Don't Die longevity project
Bryan Johnson is the tech entrepreneur behind 'Blueprint' and the 'Don't Die' movement, who reportedly spends millions a year measuring and optimizing his biology. He is among the most aggressive adopters in this index: he received follistatin gene therapy abroad (it is not available in the US) and sells a multi-peptide topical serum through Blueprint, documenting results publicly and in granular detail. Inclusion is documentation, not endorsement; several interventions he pursues are experimental and not consumer products.
Received my first gene therapy: follistatin.
Received follistatin gene therapy abroad; reports follistatin +160% (2 weeks post) and muscle mass +7%. Sells a multi-peptide topical serum via Blueprint.
Received it abroad; reported follistatin +160% and muscle mass +7%. Experimental — not a consumer product.
Among the biomimetic peptides in his Blueprint topical serum.
TB-500 is a thymosin β4 fragment; β4 appears in his serum formulation.
Another peptide growth factor in the Blueprint serum lineup.